Directors Report of N G Industries Ltd.

Mar 31, 2024

Your Directors have pleasure in presenting the 30^th Annual Report on the affairs of the Company together with the Audited Financial Statements for the financial year ended on 31st March, 2024.

FINANCIAL RESULTS:

The financial results of the Company for the year ended 31*'' March, 2024 is summarized below:

Rupees in Thousands

Particulars	2023-24	2022-23
Revenue from Operations	16,88,23.28	18,70,34.40
Other Income	4,50,60.26	8,37,48.18
Profit Before Financial Cost, depreciation, exceptional items and tax	6,46,56.74	10,18,72.30
Less: Financial Costs	1,60.15	1,32.60
Profit before Depreciation, exceptional items and Tax	6,44,96.59	10,17,39.70
Less:
A) Depreciation	59,55.60	52,49.56
B) Provision for Taxation
- Current Tax	81,50.00	1,28,70.00
- Deferred Tax	3,41.98	3,07.58
- Adjustment of tax relating for earlier years	(2,88.36)	1,52.95
Net Profit/ (Loss) after Tax	5,03,37.37	8,31,59.61
Total comprehensive income for the year	9,10,61.19	5,46,39.15
Balance carried forward to Balance Sheet	9,10,61.19	5,46,39.15

OPERATIONS AND PROSPECTS :

We are happy to present the Annual Report in this, the 30^th year of our inception. 1994-2024: Three decades since our steadfast commitment to our mission - to bring Complete Healthcare of excellent standards in an affordable manner to all Citizens.

It was an incredible journey, filled with struggles and challenges - from raising finances to obtaining regulatory approvals, from building an efficient, affordable and quality infrastructure based healthcare facilities and equipping it with appropriate medical equipment, to bringing on board clinical talent. Our first establishment started operations on 1^st December 1995 as our diagnostic division in name and style of N G Medicare & Calcutta Hope Infertility Clinic.

By remaining steadily focused on our purpose, we are, almost 30 years later, one of Kolkata''s first few corporate healthcare establishments to have had the vision to venture into this sector having our small but yet a complete end to end facility of Doctor Clinics, Outpatient Services, Diagnostic Laboratory and Services, Indoor establishment having wards & ICU, Pharmacies, Home care services, Adult vaccination unit etc. Forays like ours led to the genesis of India’s private health sector, which caters to

more than seventy percent of the country’s medical needs. The quality of healthcare being delivered in the country has been lifted over the years and got tested during the Covid years.

Last four years saw us all go through Covid times and recover, it being one of a kind disruption mankind has never seen. We chose to navigate carefully and have emerged back to our normal state and have gone through the last year consolidating further at almost the same levels as our immediate preceding year and thus the current levels of our operations have to be seen as new thresholds for us to build upon afresh.

Post Covid healthcare is undergoing changes in its various aspects-technology, funding and financing costs, cost of human resources, insurance penetration including cashless services etc. Two major and large Hospital chains of Kolkata changed hands. Big changes are expected in the coming year or two in the depth and scale of insurance coverage, its operational methodologies, digitalisation of all health records, unique health numbers for citizens etc. We look forward to engaging in such changes and are prepared to move accordingly to serve citizens seamlessly. Company has shown agility and resilience to overcome and mitigate the impact of events over the past few years whilst aligning itself to new developments.

We at NG have never chased growth at the cost of quality of services nor compromising on basic ethical principles governing our industry and people who function therein. We have thus been prudent in policies and trajectories which have helped us continue to remain a debt free company and have disbursed our dividends continuously for decades except for two Covid years.

We consider your company''s performance for the year 2023-24 as satisfactory in the context of the above described industry scenario and believe that the outlook of the company can be one of further recovery and consolidation and we hope the same to be achieved in the coming years.

There was no change in the nature of the business of the Company during the year.

As we look to the future, our determination to steadfastly stay on course and provide truly ethical excellent healthcare experience remains unswerving. We want to extend our heartfelt thanks to each and every one of you for placing your trust in us. It is an incredible honour to be your partner on this journey towards improved health and wellbeing. To the esteemed members of the Board, We would like to express our deepest gratitude for their unwavering trust and steadfast support throughout our journey. We take this opportunity to inform you regarding the changes in the Board of Directors. Mr J. C. Kumbhat and Mr Raj Kumar Bajoria have served on our board for long years and their tenure has ended now. We express our heartfelt appreciation for the support received from them and wish them all the best in their future endeavours. We also extend a warm welcome to the new Non Executive Independent Directors Mr. Pramod Kumar Dhelia and Mr. Satya Prakash Tolasaria To our esteemed shareholders, thank you for the tremendous belief you have shown in our vision, which empowers us to reach new heights in healthcare delivery. We are immensely grateful

to our NG family, whose unconditional support fills us with the confidence to explore new frontiers in healthcare services. Together, we will continue making a positive impact on people’s lives.

DIVIDEND AND TRANSFER TO RESERVE:

The Board is pleased to recommend a dividend of ? 3.50 per Equity Share of ? 10 each (i.e. 35%) for the year ended March 31, 2024. The said dividend on equity shares is subject to the approval of the shareholders at the ensuing Annual General Meeting (“AGM”) scheduled to be held on Saturday, September 28, 2024. Dividend will be paid after it is approved at the forthcoming Annual General Meeting. Also, the Board of Directors of the Company has decided not to transfer any amount to the Reserves for the year under review.

TRANSFER OF DIVIDEND AND CORRESPONDING EQUITY SHARES TO INVESTOR EDUCATION AND PROTECTION FUND:

In accordance with the provisions of Sections 124 and 125 of Companies Act, 2013 and Investor Education and Protection Fund (Accounting, Audit, Transfer and Refund) Rules, 2016 (IEPF Rules), dividends not encashed / claimed within seven years from the date of transfer to unpaid dividend account are to be transferred to the Investor Education and Protection Fund (IEPF) Authority.

The IEPF Rules mandate Companies to transfer shares of Members whose dividends remain unpaid / unclaimed for a continuous period of seven years to the demat account of IEPF Authority. The Members whose dividend / shares are transferred to the IEPF Authority can claim their shares / dividend from the Authority. In accordance with the said IEPF Rules and its amendments, the Company had sent notices to all the Shareholders whose shares were due to be transferred to the IEPF Authority and simultaneously published newspaper advertisements. List of such shareholders are also posted on the website (www.nqind.com) of the Company.

In terms of the provisions of Investor Education and Protection Fund (Accounting, Audit, Transfer and Refund) Rules, 2016, * 44,961 of unpaid / unclaimed dividends and 920 shares were transferred during the financial year 2023-24 to the Investor Education and Protection Fund. The Company has uploaded the details of unpaid and unclaimed amounts lying with the Company as on 31st March, 2023 on the Company’s website at www.ngind.com and on the website of the Ministry of Corporate Affairs at www.iepf.qov.in.

SHARE CAPITAL:

There is no change in the capital structure of the Company.

DETAILS OF DEMAT/UNCLAIMED SUSPENSE ACCOUNT:

The Company does not have any shares in the demat suspense account or unclaimed suspense account.

DISCOUNT TO SHAREHOLDERS :

The Company has decided to offer a discount of 15% to all shareholders of the Company on all the diagnostic services being offered by us. The shareholders availing the discount will be required to state their Folio number/DP ID and produce only identity documents.

AUDITORS AND AUDITORS’ REPORT:

(a) Statutory Auditors

M/s. M. R. Singhwi & Co., Chartered Accountants, (Firm Registration No. 312121E) were appointed as statutory auditors of the Company to hold the office from the conclusion of 28^th Annual General Meeting held on 24th September 2022 till the conclusion of the 33^rd Annual General Meeting of the Company to be held in the calendar year 2027.

Auditors’ Report

The Auditors’ Report given by M/s M. R. Singhwi & Co., Statutory Auditors on the financial Statement of the Company for the year ended March 31, 2024, does not contain any qualification, reservation, adverse remark. During the year under review, the Auditors had not reported any matter under section 143(12) of the Companies Act, 2013, therefore no detail is required to be disclosed pursuant to Section 134(3)(ca) of the Act.

(b) Secretarial Auditor .

In accordance with the provisions of the Section 204 read with the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, the Secretarial Audit was carried out by S. Rath & Co., Practicing Company Secretary for the financial year 2023-24. The report of Secretarial Auditor for the financial year 2023-24 is annexed herewith marked as Annexure I to this Report. The Secretarial Audit Report does not contain any qualification, reservation or adverse remark. In regard to the observations of the Secretarial Auditor on unspent CSR amount, the Board has clarified that the unspent CSR Amount shall be transferred to a Fund specified in Schedule VII, within a period of six months of the expiry of the financial year in due compliance with section 135(5) of the Companies Act,2013.

The Company has obtained Annual Secretarial Compliance Report as required under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,from Mr. Sahadeb Rath, Practicing Company Secretary and the same has been submitted to Stock Exchange.

DIRECTORS & KEY MANAGERIAL PERSONNEL :

Retirement by rotation

Pursuant to the provisions of Section 152 of the Companies Act, 2013 and the Articles of Association of the Company, Mr.Rajesh Goenka (DIN: 00157319) will retire by rotation at the 30^th Annual General Meeting ("AGM”) and being eligible, has offered himself for reappointment. Based on the performance evaluation and recommendation of NRC, the Board recommends his reappointment.

The Board at its meeting held on 23^rd May 2024, on basis of the recommendation of the Nomination and Remuneration Committee had approved the re-appointment of Mr.Rajesh Goenka (DIN: 00157319) as the Whole-time director of the Company for a period of Three years with effect from 1^st September 2024 to 31^st August 2027 subject to approval of the shareholders at the ensuing 30^th Annual General Meeting.

Second Term of Mr. Raj Kumar Bajoria (DIN-00226530) as Non-Executive & Independent Director of the Company continues till the close of the ensuing Annual General Meeting of the Company.

Second Term of Mr. Jagdish Chand Kumbhat (DIN-00005412) as Non-Executive & Independent Director of the Company continues till the close of the ensuing Annual General Meeting of the Company.

NEW APPOINTMENTS

The Board of Directors of the Company at its meeting held on 23^rd May 2024, on the recommendation of Nomination and Remuneration Committee (NRC), approved the appointment of Mr.Pramod Kumar Dhelia (DIN: 00649782) and Mr. Satya Prakash Tolasaria (DIN: 00671904) as Non-Executive Independent Directors of the Company, not liable to retire by rotation, to hold office for a term of 5 (five) consecutive years commencing from the ensuing 30^th Annual General Meeting. The notice convening the 30^th AGM sets out the details.

In terms of the provisions of rule 8(5)(iiia) of the Companies (Accounts) Rules, 2014, the Board opines that the Independent directors so appointed hold highest standards of integrity and possess necessary expertise and experience.

Declaration from Independent Directors

The Company has received declaration from all the Independent Directors confirming that they meet the criteria of Independence as prescribed under Section 149(6) of the Companies Act, 2013 read with the schedules and rules made there under along with declaration for compliance with clause 16 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Managerial Personnel

Mr. Rajesh Goenka, Chairman & Whole-time Director, Mr. Santosh Kumar Thakur, CFO and Mr. S Prasad, Company Secretary are the KMPs of the Company in terms of Section 203 of the Companies Act, 2013 read with the Companies (Appointment & Remuneration of Managerial Personnel) Rules, 2014.

Mr. Dipak Kumar Shaw resigned as Company Secretary of the Company with effect from 14^m February 2024 and Mr. S Prasad appointed as Company Secretary of the Company with effect from 3^rd May, 2024.

SUBSIDIARIES, JOINT VENTURE OR ASSOCIATE COMPANIES :

The Company does not have any Subsidiary / Joint venture or Associate Company within the meaning of the Companies Act, 2013.

WHISTLE BLOWER MECHANISM :

This has been discussed in detail in the Corporate Governance Report forming part of this Report.

LOANS, INVESTMENT AND GUARANTEES BY THE COMPANY :

There was no transaction falling under the provision of Section 186 of the Companies Act, 2013 during the financial year under review.

MEETINGS OF BOARD :

Four Meetings of the Board of Directors were held during the year. For further details, please refer to the report on Corporate Governance given separately in the Annual Report.

DETAILS OF THE COMMITTEE OF DIRECTORS :

Composition of Audit Committee of Directors, Nomination and Remuneration Committee of Directors and Stakeholders Relationship Committee of Directors, number of meetings held of each Committee during the financial year 2023-24 and meeting attended by each member of the Committee as required under the Companies Act, 2013, are provided in Corporate Governance Report forming part of this Annual Report.

The Recommendations by the Audit Committee, as and when made, to the Board have been accepted.

DIRECTOR REMUNERATION POLICY:

The Company has followed a Policy on Appointment and Remuneration of Directors, Key Managerial Personnel and senior management personnel. The criteria for determining qualifications, positive attributes, independence of a Director, performance evaluation of Board, Committees and the Directors are laid down under the Nomination and Remuneration Policy of the Company. The performance evaluation of the Board, its Committees and of individual Directors was made by structured questionnaire and the Directors were satisfied with the evaluation process. Remuneration Policy for Directors, Key Managerial Personnel and other employees of the Company may be accessed on the Company’s website at the link: http://www.ngind.com/docs/Nomination%20and%20Remuneration%20Policy.pdf. The

recommendation made by the Nomination and Remuneration Committee were accepted by the Board.

INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY :

Internal Audit has been conducted throughout the organization, by qualified outside Internal Auditors. Findings of the Internal Audit Report are reviewed by the top management and by the Audit Committee of the Board and proper follow up action is ensured wherever required. The Statutory Auditors have evaluated the systems of internal controls of the Company and have reported that the same are adequate and commensurate with the size of the Company and nature of its business.

DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND REDRESSAL ) ACT, 2013:

The Company has put in place, an Internal Complaints committee to redress complaints received regarding sexual harassment from any employee of the Company. The committee, composed of a majority of women employees is constituted for the

purpose of ensuring compliance towards the provisions of the above Act. During the year 2023-24, no complaints were received by the said committee. The Company’s Policy for Prevention, Prohibition and Redressal of Sexual Harassment may be accessed on the Company’s Website at the following link https://nqind.com/docs/Policv%20for%20Prevention,%20Prohibition%20&%20Redress al%20of%20sexual%20harassment.pdf.

LISTING WITH STOCK EXCHANGES :

As per the requirement of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company hereby declares that the Listing of its Shares at The Calcutta Stock Exchange Ltd. as well as at BSE Ltd were continued throughout the year and the Listing Fee due till date stands paid.

DEMATERIALISATION OF SHARES :

In order to facilitate dealing in shares in the electronic mode, your Company has entered into an arrangement with the National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). With this, the

Members have the option to trade their dematerialised shares in the Company through NSDL or CDSL. Securities and Exchange Board of India (SEBI) has made it mandatory for all investors to trade in the shares of the Company in dematerialised form. The Company''s Shares have been allotted ISIN.INE825C01018.

The Company has not issued any sweat equity shares, bonus and employee stock option and not called for buyback of shares during the current financial year. Directors also confirm that there are no shares under suspense status.

COST AUDIT:

Cost Audit is not applicable to the Company.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO:

The particulars as prescribed under Section 134(3) (m) of the Companies Act, 2013 read with Rule 8(3) of the Companies (Accounts) Rules 2014 are as follows:

A. CONSERVATION OF ENERGY

(i) The steps taken / impact on conservation of energy;

The operations of the Company, being healthcare, the Company is taking every necessary step to reduce the consumption of energy.

(ii) The steps taken by the Company for utilizing alternate source of energy;

Your Company is exploring the possibility of utilizing alternate sources of energy, which may be taken up for future Implementation when found to be credible and viable.

(iii) The capital investment on energy conservation equipment;

Though investments have been made in areas like change over to LED lights, Energy audits, load balancing, replacement with energy saving air conditioners etc., no specific budgets or heads of such are accounted for, in view of major energy specific projects being yet to be taken up.

B. TECHNOLOGY ABSORPTION

The nature of the Company’s operations being healthcare, the required information in the prescribed manner is considered to be not applicable to the Company.

C. FOREIGN EXCHANGE EARNINGS & OUTGO

FOREIGN EXCHANGE EARNINGS AND OUTGO (Rupees in Lakh)

2023-24_2022-23

EARNINGS NIL Nil

OUTGO 4.13 Nil

RISK MANAGEMENT:

The provisions relating to composition of a Risk Management Committee are not applicable to the Company.

CORPORATE SOCIAL RESPONSIBILITY:

As per Section 135 of the Companies Act, 2013, a company, meeting the applicability threshold, needs to spend at least 2% of its average net profit for the immediately preceding three financial years on corporate social responsibility (CSR) activities. During the year under review, the Company has allocated a sum of ?9.20 lakhs for CSR activities based on the average of the last three years’ profit before tax. This being the first year of applicability of the provision of CSR , the company endeavored to meet the budgeted expenditure by contributing in various eligible CSR activities within the Financial Year and with this objective initiated steps in right direction to identify suitable implementing agency(ies) carrying on eligible CSR activities in local area around which it operates and to actively engage with this agency(ies) for effective utilization of the said allocated fund of the Company. Despite adequate effort the Company was unable to find a suitable Implementing agency within the financial Year for effective utilization of the contribution to CSR in the manner and purpose for which the amount was allocated by the Board. The Company has committed to transfer the said Unspent CSR amount of ?9.20 lakhs to a Fund specified in Schedule VII, within a period of six months of the expiry of the financial year 2023-24 in compliance with section 135(5) of the Companies Act,20I3.

Further, in light of the amended Companies (Corporate Social Responsibility Policy) Rules, 2021 where the amount to be spent by a company under sub-section 5 of section 135 does not exceed Rs. 50 Lakhs, the requirement under sub-section 1 of section 135 for constitution of the Corporate Social Responsibility Committee shall not be applicable and in such cases the functions of such Committee shall be discharged by the Board of Directors; hence CSR Committee is not constituted by the Company.

The annual report on Corporate Social Responsibility activities, as required under Sections 134 and 135 of the Companies Act, 2013 read with Rule 8 of the Companies (Corporate Social Responsibility Policy) Rules, 2014 and Rule 9 of the Companies (Accounts) Rules, 2014, is provided in the Annexure forming part of this Report. The Board, at its meeting held on 19^th May 2023 approved and adopted the CSR Policy of the Company.

Your company is in compliance with the statutory requirement in this regard.

PARTICULARS OF EMPLOYEES & MANAGERIAL REMUNERATION:

Disclosure of Remuneration under Section 197 of the Companies Act, 2013 and Rule 5(1) of Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014.

i: Ratio of remuneration of each Executive Director to median remuneration of the employees of the Company for the financial year 2023-24, percentage increase in remuneration of Directors, Chief-Financial Officer and Company Secretary during the financial vear 2023-24:

SI. No.	Name of Director(s)/KMP	Designation	Ratio of remuneration of director to median employee remuneration	Percentage increase in Remuneration
1	Rajesh Goenka	Chairman & Whole-time Director	10.09	-
2	Santosh Kumar Thakur	CFO	N.A.	13.46
3	Dipak Kumar Shaw (resigned with effect 14.02.2024)	Company Secretary	N.A.	0.92

ii: The percentage increase in the median remuneration of Employees for the financial year 2023-24 was 14.75.

iii: The Company has 64 permanent employees (excluding Whole-time Director) on the rolls of the Company as on 31st March, 2024

iv It is hereby affirmed that the remuneration paid during the year, is as per the Remuneration Policy of the Company.

DIRECTORS’ RESPONSIBILITY STATEMENT :

Your Directors state that:

• In the preparation of the annual accounts for the financial year ended on 31^st March, 2024, the applicable accounting standards had been followed along with proper explanation relating to material departures;

• Such accounting policies have been selected and applied consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company as at 31^s'' March, 2024 and of profit of the Company for that period;

• the Directors have taken proper and sufficient care for the maintenance of adequate accounting records jn accordance with the provisions of the Companies Act, 2013, for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

• the annual accounts have been prepared on a going concern basis

• internal financial controls have been laid down so that the same can be followed by the Company and that such internal financial controls are adequate and are operating effectively and proper systems have been devised to ensure compliance with the provisions of all applicable laws and such systems are adequate and operating effectively.

MANAGEMENT DISCUSSION & ANALYSIS

Our discussion & analysis may be perceived as repetitive over the years but constitutes the essence of wisdom about our field of operations as assimilated by us with close to three decades of experience.

A) INDUSTRY STRUCTURE & DEVELOPMENT:

Rising incomes in the hands of our citizens, increase in health awareness in society at large, increasing population of older citizens, new technologies in the sector, longer life expectancy, health insurance penetration and medical tourism are contributing to the growth in the healthcare sector. The new health Insurance schemes announced by the Union Government, when fully implemented, as well as the State Government having introduced health-card schemes will further increase penetration of insured healthcare in the country. Policy planners in the country are aiming at covering the entire population with a minimum health insurance coverage enabling thereby all our citizens to be able to access quality healthcare.

Covid-19 is an unprecedented, new, unknown, disruptive development which has hit globally as a whole including all countries, economies, sectors, companies and has affected in more ways than one can imagine. The Company has released separate disclosure regarding impact of the pandemic and the challenges it has posed and the same is available on our website under ‘Information & Circulars for Shareholders." We have also discussed it under ‘Operations and Prospects'' in our past Annual Reports. We have now put behind this unprecedented Pandemic and look ahead towards recovery and consolidation. We keep referring to it, because its imprint in our field will be felt by generations and we cannot afford to forget the lessons of this disruption.

Digitalisation & Al based new generation of equipment, technologies, diagnosing tools, treatment and surgical skills & outcomes are making ours a very exciting sector.

B) OPPORTUNITIES, THREATS, RISKS AND CONCERNS:

Opportunity for the Company is inherent in the sectors we operate in and are already covered in above paragraph (A). Digitalisation & Al based new generation of equipment, technologies, diagnosing tools, treatment and surgical skills & outcomes are making ours a very exciting sector.

Slowdown in the economy, especially in the services or retail sector affects most businesses including healthcare. The healthcare business runs the risk of unfavorable publicity in case of unsuccessful treatment, translating into reduction of patient flow, risk of good professionals leaving the Company and it stands to lose years of on job training and risk of independent Doctors beginning to refer patients elsewhere. Doctors use our Clinic Services and many Doctors whose patients frequently use our services due to locational proximity etc. Disruption of Doctors Clinics as it has happened significantly during Covid has meant rebuilding such outreach on a continuous basis. At present we are in process of rebuilding once again.

Healthcare services being an area affecting the entire population is automatically politically sensitive and from time to time is subjected to threats of over regulation /tariff control measures etc. These have always proved to be counterproductive the world over and the industry can only by expanding and using technology moderate costs and hope to get this message across to citizens as well as regulators.

Healthcare establishments have faced mob violence and damage to property, increased litigation for award of compensation on sometimes frivolous grounds; doctors have been taken to Medical Council for action on grounds of negligence etc. This challenge will have to be met by all, with more transparent and diligent services. The pandemic also added to the major challenges in terms of employee attrition as well as professional changes being adopted by doctors as well as paramedical professionals. The company however recognizes these issues as concerns. Governments have also strengthened regulatory oversight systems as well as enabled more punitive measures to tackle lawlessness at hospitals.

The Company mitigates these risks, through adopting ethical practices, transparent dealings with patients and explaining to them, in plain layman’s language, the pros and cons of the treatment with realistic assessments of recovery. Quality surveillance and adherence to strict protocols also mitigates risks. The Company provides its professionals, a very good and challenging environment with continuous growth and also looks out to induct new and good professionals to keep strengthening its team. The Company has also adopted external quality audits as well as accreditations. To face competition, the Company keeps close interaction with doctors and strives to keep services at levels meeting their standards. The Company is also continuously investing in newer technologies and equipment to stay ahead, in offering value added and superior quality of tests at affordable tariffs.

C) OUTLOOK:

Our Company operates in an industry which is increasingly getting more competitive and yet we state with conviction that the long-term outlook of your Company looks good on account of our adherence to quality of services, affordable tariffs and trust earned through nearly three decades of diligent service to citizens. The Company is facing all challenges through consistent, credible and transparent dealings and greater communication with patient’s families on all aspects of treatment. Covid-19 impact has been indicated in the “Company Disclosures” released separately earlier and our experience during the year will further help us reorient our strategies and adapt ourselves for the post Covid-19 ecosystem. Our, over two decades of trust and goodwill will help us move ahead and get the Company''s operations back on track soon. Our vaccination outreach, we hope, has earned us significant goodwill and exposure and we continue this activity as well.

D) INTERNAL CONTROL:

Your Company has adequate internal control systems, which commensurate with its size of operations. Please see the paragraph with heading ‘internal control systems and their adequacy’ j_n this report.

E) HUMAN RESOURCES/INDUSTRIAL RELATIONS:

Your Company has during the previous year continued to have cordial industrial relations with its employees. The number of employees of the Company at the end of the year was 64 (excluding full-time director). Pandemic has led to some employees to leave their jobs out of resulting compulsions and even many Doctors chose not to continue Clinics at our premises.

F) FINANCIAL AND OPERATIONAL PERFORMANCE:

This has already been detailed earlier in this report.

CORPORATE GOVERNANCE:

The Corporate Governance Report forms an integral part of this Report and has been set out as a separate annexure to this Report. The certificate from the Auditors of the company, certifying compliance of conditions of Corporate Governance stipulated in the Listing Agreement with the Stock Exchanges is also annexed to Report on Corporate governance.

CONTRACTS AND ARRANGEMENTS WITH RELATED PARTY :

All contracts / arrangements / transactions entered by the Company during the financial year with related parties were in the ordinary course of business and on an arm’s length basis.

During the year, the Company had not entered into any contracts / arrangements / transactions with related parties which could be considered material in accordance with the policy of the Company on materiality of related party transactions.

Your Directors draw attention of the members to the notes of the financial statement which sets out related party disclosures.

EXTRACT OF ANNUAL RETURN :

As provided under Section 92(3) & 134(3)(a) of the Act, the Annual Return for FY 2023-24 is uploaded on the website of the Company and can be accessed at www.ngind.com.

DEPOSITS:

The Company has not accepted any deposits from the public during the period under review and accordingly no amount was outstanding as on the date of the Balance Sheet.

SECRETARIAL STANDARDS:

The Company is in compliance with applicable Secretarial Standards issued by the Institute of Company Secretaries of India, New Delhi.

SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS;

There are no significant and material orders passed by the Regulators/Courts that would impact the going concern status of the Company and its future operations.

MATERIAL CHANGES AND COMMITMENTS AFFECTING THE FINANCIAL POSITION OF THE COMPANY:

There have been no material changes and commitments, if any, affecting the financial position of the Company which have occurred between the end of the financial year to which the financial statements relate and the date of the report.

ACKNOWLEDGEMENTS:

Your Directors acknowledge the co-operation and assistance received from the Shareholders, Doctors, Banks and various Government Agencies. Your Directors wish to place on record their sincere appreciation for the contribution made by the employees.

Place : Kolkata For and on behalf of Board of Directors

Date : 23^rd day of May, 2024 y

Rajesh Goenka Chairman

---

Mar 31, 2016

DIRECTORS'' REPORT TO THE MEMBERS:

The Directors have pleasure in submitting the 22nd Annual Report together with the Audited Statement of Accounts for the year ended 31st March, 2016.

FINANCIAL HIGHLIGHTS:

The financial results of the Company are summarized below:

Particulars	Year ended 31st March 2016 (Rs.in lacs)	Year ended 31st March 2015 (Rs.in lacs)
Income from Operations	1,693.02	1486.49
Other Income	(6.80)	52.99
Total Income	1,686.22	1,539.48
Total Expenditure	1,385.68	1,220.19
Interest	0.84	4.32
Depreciation	58.09	119.24
Profit before Taxation	241.61	195.73
Provision for Taxation
Current Tax	81.90	65.20
Deferred Tax	4.75	(12.92)
Income Tax Adjustment for the earlier year	1.83	0.53
Net Profit	153.13	142.92
Proposed Dividend	117.27	117.27
Tax on Dividend	23.87	23.45
Earnings per Share (Rs.)	4.57	4.27

OPERATIONS AND PROSPECTS:

The Company''s three divisions namely N G Medicare & Calcutta Hope Infertility Clinic, N G Nursing Home and N G Pharmacy could muster modest growth in the increasingly competitive environment in this sector. Despite these challenges, we consider your Company''s performance as satisfactory. This year your Company completed 20 years of its operations and it gives us immense satisfaction to report that we have remained throughout as an ethical, efficient and have pursued our long term strategy to improve our long term competitiveness in the business through operational excellence. The outlook of the Company can be thus in line with its current performance.

There was no change in the nature of the business of the Company during the year. DIVIDEND:

Your Directors recommend a Dividend of Rs. 3.50 per Equity Share (Previous Year Rs.3.50) for your consideration for the year ended 31st March, 2016. The Dividend will be paid after it is approved at the forthcoming Annual General Meeting.

TRANSFER TO GENERAL RESERVE:

A sum of Rs.15, 35,000/- has been transferred to the General Reserves of the Company TRANSFER TO INVESTOR EDUCATION & PROTECTION FUND:

In terms of section 125 of the Companies Act, 2013, dividends unpaid/unclaimed up to that for financial years 2007-2008, which remain unpaid or unclaimed for a period of 7 (Seven) years have been deposited in the Investor Education & Protection Fund (IEPF) established by the Central Government.

DIRECTORS & KEY MANAGERIAL PERSONNEL:

Mr Ashok Kumar Goenka has been one of the first founding Directors of the Company and has served and provided leadership and guidance to the board for past two decades .He has relinquished his position as Chairman of the company from 30th May 2016 due to his other commitments .The board wishes to place on record its sincere appreciation for the long and unstinted service and leadership with dedication that he has provided. Mr Ashok Kumar Goenka, Director of the company retires by rotation and for the same reasons as stated herein before he has conveyed his decision not to seek re-appointment in the ensueing Annual General Body Meeting. The board has decided not to appoint anyone else in his place at present.

Mr. Rajesh Goenka, Director of the Company, retires by rotation and being eligible offers himself for re-appointment in the ensueing Annual General Body Meeting.

Mr Rajesh Goenka has been elected by the board as the Chairman of the board of directors of the company with effect from 30th May 2016.

The Company has designated Mr. Rajesh Goenka, Whole-time-Director & Chairman, Mr. Santosh Kumar Thakur- Chief Financial Officer and Mr. Pritam Paul - Company Secretary & Compliance Officer as Key Managerial Personel. Mr. Santosh Kumar Thakur was appointed as CFO with effect from 28th September, 2015 and Mr. Pritam Paul was appointed Company Secretary & Compliance Officer with effect from 28th September, 2015.

ARTICLES OF ASSOCIATION OF THE COMPANY

The board has approved adoption of newly substituted Articles of Association of the Company containing regulations in line with the Companies Act, 2013, and suitable resolution for the approval of members will be sought in the forthcoming annual general meeting.

SUBSIDIARIES, JOINT VENTURE OR ASSOCIATE COMPANIES:

The Company does not have any Subsidiary/ Joint venture or Associate Company within the meaning of the Companies Act, 2013.

WHISTLE BLOWER MECHANISM:

The Company has put in place Whistle Blower Mechanism, details of which are given in Corporate Governance Report forming part of this report.

LOANS, INVESTMENT AND GUARANTEES BY THE COMPANY:

There is no loan given, investment made, guarantee given or security provided by the Company to any entity under Section 186 of the Companies Act, 2013.

NUMBER OF MEETING OF BOARD OF DIRECTORS:

The Board of Directors have met 8 times and Independent Directors once during the year ended 31st March, 2016.Details of the meetings and attendance of the Directors are provided in the Corporate Governance Report.

DETAILS OF COMMITTEE OF DIRECTORS:

Composition of Audit Committee of Directors, Nomination and Remuneration Committee of Directors and Stakeholders Relationship Committee of Directors, number of meetings held of each Committee during the financial year 2015-2016 and meetings attended by each member of the Committee as required under the Companies Act, 2013 are provided in Corporate Governance Report and forming part of this Report.

The Recommendations by the Audit Committee as and when made to Board have been accepted. DIRECTOR REMUNERATION POLICY:

The Company has followed a Policy on Appointment and Remuneration of Directors and senior management employees. This policy is approved by the nomination & remuneration committee and the board. Details of the same are covered under Corporate Governance Report.

ANNUAL EVALUATION BY THE BOARD OF ITS OWN PERFORMANCE, ITS COMMITTEES AND INDIVIDUAL DIRECTORS:

The Board of Directors of the Company has initiated and put in place a policy for evaluation of its own performance, its Committees and individual directors. The result of the evaluation is satisfactory and adequate and meets the requirement of the Company. Further details are outlined in the Corporate Governance Report forming a part of this report.

DECLARATION OF INDEPENDENCE BY THE INDEPENDENT DIRECTORS:

Pursuant to Section 149(6) of the Companies Act, 2013, Independent Directors of the Company have made a declaration confirming the Compliance of the Conditions of the independence stipulated in the aforesaid section.

INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY:

Internal Audit has been conducted throughout the organization by qualified outside Internal Auditors. Findings of the Internal Audit Report are reviewed by the top management and by the Audit Committee of the Board and proper follow up action are ensured wherever required. The Statutory Auditors have evaluated the systems of internal controls of the Company and have reported that the same are adequate and commensurate with size of the Company and nature of its business.

DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013:

The Company has put in place an Internal Complaints committee to redress complaints received regarding sexual harassment from any employee of the Company. The committee comprising of majority of women employees is constituted for the purpose of ensuring Compliance towards the provisions of the above Act. During the year 2015-2016 no complaints were received by the said committee.

LISTING WITH STOCK EXCHANGES:

As per the requirement SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Company hereby declares that the Listing of its Shares at The Calcutta Stock Exchange Association Ltd. as well as BSE Limited continued throughout the year and the Listing Fee due till date stands paid.

DEMATERIALISATION OF SHARES:

In order to facilitate dealing in shares in the electronic mode, your Company has entered into an arrangement with the National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). With this, the members have the option to trade their dematerialized shares in the Company through NSDL or CDSL. Securities and Exchange Board of India (SEBI) has made it mandatory for all investors to trade in the shares of the Company in dematerialized form. The Company''s Shares have been allotted ISIN: INE825C01018.

The Company has not issued any sweat equity shares, bonus, and employee stock option and not called for buyback of shares during the current financial year. Directors also confirm that there are no shares under suspense status.

AUDITORS AND AUDITOR''S REPORT:

M/s. M. R. Singhwi & Co., Chartered Accountants, Kolkata, Auditors of the Company, retire and being eligible offer them for re-appointment. The notes on account referred to, in the Auditor''s Report are self- explanatory and therefore do not call for further explanation. There are no qualifications in their report requiring explanation from the board.

COST AUDIT:

Cost Audit is not applicable to the Company.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO:

The particulars as prescribed under Section 134(3) (m) of the Companies Act, 2013 read with Rule 8(3) of the Companies (Accounts) Rules 2014 are as follows

A. CONSERVATION OF ENERGY

(i) The steps taken or impact on conservation of energy;

The operations of the Company, being healthcare establishments the Company is taking every necessary step to reduce the consumption of energy.

(ii) The steps taken by the Company for utilizing alternate source of energy;

Your Company is exploring the possibility of utilizing alternate sources of energy which may be taken up for future implementation when found to be credible and viable.

(iii) The capital investment on energy conservation equipment:

Though investments have been made in areas like change over to LED lights, Energy audits, Load balancing, Replacement with energy saving air conditioners etc no specific budgets or heads of such are accounted for ,in view of major energy specific project being yet to be taken up.

B. Technology Absorption

The nature of the Company''s operations being healthcare delivery, the required information in the prescribed manner is considered to be not applicable to the Company.

C. Foreign Exchange Earnings & Outgo

During the year under review, there were no inflow & outgo of Rs.3, 29,486 of Foreign Exchange.

RISK MANAGEMENT

The provisions relating to composition of a Risk Management Committee are not applicable to the Company.

CORPORATE SOCIAL RESPONSIBILITY

Provisions relating to Corporate Social Responsibility are not applicable to the Company

PARTICULARS OF EMPLOYEES & MANAGERIAL REMUNERATION:

Pursuant to Rule 5(2) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, there are no employees getting remuneration exceeding the limit.

Pursuant to Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, details areas detailed below

Remuneration etc Pursuant to Section 197(12) and Rules made there under are as below. The ratio of the remuneration of Director to the median employee remuneration for the year

i) Name: Shri Rajesh Goenka (Chairman & Whole time Director) - Ratio 9.21:1

ii) The percentage increase in remuneration of Directors, Chief Financial Officer, Company Secretary

1. Rajesh Goenka (Chairman & Whole time Director) : 8.93%

2. Santosh Kumar Thakur (CFO): First year in appointment.

3. Pritam Paul (Company Secretary): First year in appointment.

iii) The percentage increase in the median remuneration of employees in the financial year: 16.16%

iv) There were 82 permanent employees on the rolls of the Company as on March 31, 2016.

v) Explanation on the relationship between average increase in Remuneration and Company performance: There is practically no increase in the remuneration of Rajesh Goenka except for subscription by the Company to NPS account on his behalf. The net profit of the Company rose from Rs.142.92 lacs to Rs.153.13 lacs. An increase of 7.14%. However average increase of remuneration of employees is 19.12% and this increase is considered justified taking into consideration the inflation and other factors.

vi) Comparison of the remuneration of the Key Managerial Personnel (KMP)against the performance of the Company: The increase in the remuneration of KMP (excluding that of Chairman & Whole time Director) is not applicable since they are first year appointees comparison to the increase in net profit of the company of 7.14% is not provided.

vii) The market capitalization of the company as on 31st March, 2016 decreased by 10.84%, when compared to that of 31st March, 2015. The Company has not made any public offer in the recent past and according comparison of public offer price and the current market price of the Company''s shares will not be relevant.

viii) Key Parameter of any variable component of remuneration availed by the director - No variable component is paid.

ix) There is no such employees in the company who received remuneration in excess of the highest paid director during the year.

x) It is hereby affirmed that the remuneration paid during the year ended 31st March, 2016 is as per the Remuneration policy of the Company.

DIRECTORS'' RESPONSIBILITY STATEMENT:

Your Directors state that:

In the preparation of the Annual Accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures.

The Directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit of the Company for that period.

The Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities.

^- The Directors have prepared the annual accounts on a going concern basis.

^- The Directors have laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and operating effectively, and

^- The Directors have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems are adequate and operating effectively.

MANAGEMENT DISCUSSION & ANALYSIS

A) INDUSTRY STRUCTURE & DEVELOPMENT:

Rising incomes in the hands of our citizens, increasing health awareness in society at large, increasing population of older citizens, new technologies in the sector, longer life expectancies, health insurance penetration, medical Tourism are contributing to the growth in healthcare sector.

B) OPPORTUNITIES, THREATS, RISKS AND CONCERNS:

The business runs the risk of unfavorable publicity in case of unsuccessful treatment translating into reduction of patient flow, risk of good professionals leaving the Company it stands to lose years of on job training and risk of Independent Doctors beginning to refer patients elsewhere. With several Medical Centres coming up in the city, competitive threats cannot be ignored.

The Company mitigates these risks through adopting ethical practices, transparent dealings with patients and explaining to them in plain layman language the pros and cons of the treatment with realistic assessments of recovery. Quality Surveillance and adherence to strict protocols also mitigates risks. The Company provides professionals a very good and challenging environment with continuous growth and also looks out to induct new and good professionals to keep strengthening its team. To face competition the Company keeps close interaction with Doctors and strives to keep services at levels meeting their standards. Company is also continuously investing in newer Technologies and equipments to stay ahead in offering value added and superior quality of tests at affordable tariffs.

C) OUTLOOK:

Although the Company operates in an industry that is increasingly getting more competitive, the outlook of your Company looks good on account of our adherence to quality of services, affordable tariffs and trust earned through two decades of diligent service to citizens,

D) INTERNAL CONTROL:

Your Company has adequate internal control systems, commensurate with its size of operations. Please see paragraph with heading INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY in this report.

E) HUMAN RESOURCES/INDUSTRIAL RELATIONS:

Your Company has during the previous year continued to have cordial industrial relations with its employees. The number of employees of the Company at the end of the year was 82.

F) FINANCIAL AND OPERATIONAL PERFORMANCE: Has been detailed already in this report. CORPORATE GOVERNANCE:

The Corporate Governance Report forms an integral part of this Report and are set out as separate annexure to this Report. The certificate from the Auditors of the company certifying compliance of conditions of Corporate Governance stipulated in the Listing Agreement with the Stock Exchanges is also annexed to Report on Corporate governance.

CONTRACTS AND ARRANGEMENTS WITH RELATED PARTY :

All contracts / arrangements/ transactions entered by the Company during the financial year with related parties were in the ordinary course of business and on an arm''s length basis. During the year, the Company had not entered into any contracts/ arrangements/ transactions with related parties which could be considered material in accordance with the policy of the Company on materiality of related party transactions.

Your Directors draw attention of the members to notes to the financial statement which sets out related party disclosures.

SECRETARIAL AUDITOR:

The Board has appointed S. Rath & Co., Practicing Company Secretary, to conduct Secretarial Audit for the financial year 2015-2016. The Secretarial Audit Report for the financial year ended 31st March, 2016 is annexed herewith to this report.

There are no qualifications in their report requiring explanation from the board. EXTRACT OF ANNUAL RETURN:

Extract of Annual Return of the Company is annexed herewith to this report. DEPOSITS:

The Company has not accepted any deposits from public during the period under review and accordingly no amount was outstanding as on the date of the Balance Sheet.

SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS.

There are no significant and material orders passed by the Regulators/Courts that would impact the going concern status of the Company and its future operations .

MATERIAL CHANGES AND COMMITMENTS AFFECTING THE FINANCIAL POSITION OF THE COMPANY:

There have been no material changes and commitments, if any, affecting the financial position of the Company which have occurred between the end of the financial year to which the financial statements relate and the date of the report.

ACKNOWLEDGEMENTS:

Your Directors acknowledge the co-operation and assistance received from the Shareholders, Doctors, Banks and various Government Agencies. Your Directors wish to place on record their sincere appreciation for the contribution made by the employees.

For and on behalf of Board of Directors

Place: Kolkata Rajesh Goenka

Date: 30th day of May, 2016 Chairman

---

Mar 31, 2015

Dear Members'

The Directors have pleasure in submitting the 21st Annual Report together with the Audited Statement of Accounts for the year ended 31st March, 2015.

FINANCIAL HIGHLIGHTS:

The financial results of the Company are summarised below:

Particulars Year ended Year ended 31st March 2015 31st March 2014 (Rs.in lacs) (Rs.in lacs)

Income from Operations 1,486.49 1,379.85

Other Income 52.99 57.05

Total Income 1,539.48 1,436.90

Total Expenditure 1,220.19 1,105.58

Interest 4.32 28.96

Depreciation 119.24 93.37

Profit before Taxation 195.73 208.99

Provision for Taxation

Current Tax 65.20 59.50

Deferred Tax (12.92) (2.39)

Income Tax Adjustment for the earlier year 0.53 -

Net Profit 142.92 151.88

Proposed Dividend 117.27 117.27

Tax on Dividend 23.45 19.93

Earnings per Share (Rs.) 4.27 4.53

OPERATIONS AND PROSPECTS:

Except for a brief period when H1N1 cases were detected in Kolkata, the year was one which did not show any epidemic challenges to Healthcare Service Providers in the city.

The Company's three divisions namely N G Medicare & Calcutta Hope Infertility Clinic, N G Nursing Home and N G Pharmacy thus could only muster modest growth in the increasingly competitive environment in this sector.

The Company has higher provisions for Depreciation arising due to the new provisions of the company Act 2013 thus resulting in lower numbers for Net Profit. Higher employee costs continue to put pressure on the Company's finances. Despite these challenges, the Company continues to perform and expects to do so in the coming year.

There was no change in the nature of the business of the company during the year.

DIVIDEND:

Your Directors recommend a Dividend of Rs. 3.50 per Equity Share (Previous Year Rs.3.50) for your consideration for the year ended 31st March, 2015. The Dividend will be paid after it is approved at the forthcoming Annual General Meeting.

DIRECTORS:

Mr. Rajesh Goenka, Director of the Company, retires by rotation and being eligible offer himself for re-appointment.

The Companies Act, 2013 and revised Clause 49 of the Listing Agreement require that a Woman Director should be member of the Board of Directors. Ms. Neha Goenka, was appointed by the Board of Directors on 16th March, 2015. Ms. Goenka holds office as an Additional Director of the Company upto the date of the ensuing Annual General Meeting. The Company has received a notice pursuant to Section 160 of the Companies Act, 2013 along with prescribed deposit from a member of the Company signifying her intention to propose the candidature of Ms. Neha Goenka for the Office of the Director of the Company.

KEY MANAGERIAL PERSONNEL:

The Company has designated Mr. Rajesh Goenka , who is Whole-time-Director as Chief Financial Officer.

SUBSIDIARIES:

The Company does not have any Subsidiary/ Subsidiaries within the meaning of the Companies Act, 2013.

WHISTLE BLOWER MESCHANISM:

The Company has put in place Whistle Blower Mechanism, details on which are given in Corporate Governance Report forming part of this report.

LOANS, INVESTMENT AND GUARANTEES BY THE COMPANY:

There is no loan given, investment made, guarantee given or security provided by the Company to any entity under Section 186 of the Companies Act, 2013.

NUMBER OF MEETING OF BOARD OF DIRECTORS:

The Board of Directors have met 8 times and Independent Directors once during the year ended 31st March, 2015

DETAILS OF COMMITTEE OF DIRECTORS:

Composition of Audit Committee of Directors, Nomination and Remuneration Committee of Directors and Stakeholders Relationship Committee of Directors, number of meetings held of each Committee during the financial year 2014-2015 and meetings attended by each member of the Committee as required under the Companies Act, 2013 are provided in Corporate Governance Report and forming part of this Report.

The Recommendations by the Audit Committee as and when made to Board has been accepted by it.

ANNUAL EVALUATION BY THE BOARD OF ITS OWN PERFORMANCE, ITS COMMITTEES AND INDIVIDUAL DIRECTORS :

The Board of Directors of the Company has initiated and put in place a policy for evaluation of its own performance, its Committees and individual directors. The result of the evaluation is satisfactory and adequate and meets the requirement of the Company. Further details are outlined in the Corporate Governance Report forming a part of this report.

DECLARATION OF INDEPENDENCE BY THE INDEPENDENT DIRECTORS:

Pursuant to Section 149(6) of the Companies Act, 2013, Independent Directors of the Company have made a declaration confirming the Compliance of the Conditions of the independence stipulated in the aforesaid section.

INTERNAL CONTROL SYSTEMS AND THEIR ADEQUACY:

Internal Audit has been conducted throughout the organization by qualified outside Internal Auditors. Findings of the Internal Audit Report are reviewed by the top management and by the Audit Committee of the Board and proper follow up action is ensured wherever required. The Statutory Auditors have evaluated the systems of internal controls of the Company and have reported that the same are adequate and commensurate with size of the Company and nature of its business.

DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION, PROHIBITION AND REDRESSAL) ACT, 2013:

The Company has put in the place an Internal Complaints committee to redress complaints received regarding sexual harassment from any employee of the Company. The committee comprising of majority of women employees is constituted for the purpose of ensuring compliance towards the provisions of the above Act. During the year 2014-2015 no complaints were received by the said committee.

LISTING WITH STOCK EXCHANGES :

As per the requirement of Clause 49 of the Listing Agreement with Stock Exchanges, the Company hereby declares that the Listing of its Shares at The Calcutta Stock Exchange Association Ltd. as well as Bombay Stock Exchange Limited continued throughout the year and the Listing Fee due till date stands paid.

DEMATERIALISATION OF SHARES :

In order to facilitate dealing in shares in the electronic mode, your Company has entered into an arrangement with the National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). With this, the members have the option to trade their dematerialised shares in the Company through NSDL or CDSL. Securities and Exchange Board of India (SEBI) has made it mandatory for all investors to trade in the shares of the Company in dematerialised form. The Company's Shares have been allotted ISIN:INE825C01018.

AUDITORS AND AUDITOR'S REPORT :

M/s. M. R. Singhwi & Co., Chartered Accountants, Kolkata, Auditors of the Company, retire and being eligible offer themselves for re-appointment. The notes on account referred to, in the Auditor's Report are self-explanatory and therefore do not call for further explanation.

COST AUDIT:

Cost Audit is not applicable to the Company.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO:

Particulars in respect of conservation of energy, technology absorption and foreign exchange earnings and outgo, as required under Section 134(3)(m) of the Companies Act, 2013 read with Rule 8(3) of the Companies (Accounts) Rules 2014 are set out in a separate statement attached hereto and forming part of the report.

PARTICULARS OF EMPLOYEES :

Pursuant to the provisions of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, there are no employees getting remuneration exceeding the limit.

DIRECTORS' RESPONSIBILITY STATEMENT:

Your Directors state that:

* In the preparation of the Annual Accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures.

* The Directors have selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit of the Company for that period.

* The Directors have taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities.

* The Directors have prepared the annual accounts on a going concern basis.

* The Directors have laid down internal financial controls to be followed by the Company and that such internal financial controls are adequate and operating effectively; and

* The Directors have devised proper systems to ensure compliance with the provisions of all applicable laws and that such systems are adequate and operating effectively.

CORPORATE GOVERNANCE :

The Corporate Governance Report forms an integral part of this Report and are set out as separate annexures to this Report. The certificate from the Auditors of the company certifying compliance of conditions of Corporate Governance stipulated in Clause 49 of the Listing Agreement with the Stock Exchanges is also annexed to Report on Corporate governance.

CONTRACTS AND ARRANGEMENTS WITH RELATED PARTY :

All contracts / arrangements/ transactions entered by the Company during the financial year with related parties were in the ordinary course of business and on an arm's length basis. During the year, the Company had not entered into any contracts/ arrangements/ transactions with related parties which could be considered material in accordance with the policy of the Company on materiality of related party transactions.

Your Directors draw attention of the members to notes to the financial statement which sets out related party disclosures.

SECRETARIAL AUDITOR :

The Board has appointed S. Rath & Co., Practicing Company Secretary, to conduct Secretarial Audit for the financial year 2014-2015. The Secretarial Audit Report for the financial year ended 31st March, 2015 is annexed herewith to this report.

EXTRACT OF ANNUAL RETURN :

Extract of Annual Return of the Company is annexed herewith to this report.

DEPOSITS :

During the period under review, your Company has not accepted any deposit from the Public.

ACKNOWLEDGEMENTS:

Your Directors acknowledge the co-operation and assistance received from the Shareholders, Doctors, Banks and various Government Agencies. Your Directors wish to place on record their sincere appreciation for the contribution made by the employees.

For and on behalf of Board of Directors

Place : Kolkata Ashok Kumar Goenka Date : 28th day of May, 2015 Chairman

---

Mar 31, 2014

Dear members,

The Directors have pleasure in submitting the 20th Annual Report together with the Audited Statement of Accounts for the year ended 31st March, 2014.

FINANCIAL HIGHLIGHTS:

The financial results of the Company are summarised below:

Particulars Year ended Year ended 31st March 2014 31st March 2013 (Rs. in lacs) (Rs. in lacs)

Income from Operations 1,379.85 1,412.91

Other Income 57.05 77.22

Total Income 1,436.90 1,490.13

Total Expenditure 1,105.58 1,120.15

Interest 28.96 12.14

Depreciation 93.37 72.70

Profit before Taxation 208.99 285.14

Provision for Taxation

Current Tax 59.50 73.70

Deferred Tax (2.39) 0.50

Income Tax Adjustment for - 2.99 the earlier year

Net Profit 151.88 207.95

Proposed Dividend 117.27 117.27

Tax on Dividend 19.93 19.93

Transfer to General Reserve 15.20 21.00

Earnings per Share (Rs.) 4.53 6.21

OPERATIONS AND PROSPECTS:

Current year being one almost free of Dengue & Malaria cases resulted in lower bed utilisation, lower pharmacy as well as investigations compared to previous year when it was of epidemic proportions. This resulted in lack of revenue growth in all the three divisions of the Company namely N G Medicare & Calcutta Hope Infertility Clinic, N G Nursing Home and N G Pharmacy .High Inflation and slower growth of the economy in general, compounded with increased competition in the sector also posed challenges to the Company.

Higher Interest & Depreciation due to investment in new premises leading to higher utilisation of Bank credit as well as introduction of VAT on Pharmacy & other Sales and consequent assessed liability for past period has affected profits for the year. Service Tax on reverse charge basis introduced late last year also increased costs.

Inflationary pressures and economic slowdown raised employee costs for service sector companies like us. Enhanced Food coupons provided to employees as well as significant higher provisions towards Gratuity Fund contributions to LIC have raised employee costs during the year.

The Company relocated its Registered Office to its own newly acquired premises from April onwards. Company continues to meet the challenges and expects to perform well in the coming year.

DIVIDEND:

Your Directors recommend a Dividend of Rs. 3.50 per Equity Share (Previous Year Rs.3.50) for your consideration for the year ended 31st March, 2014. The Dividend will be paid after it is approved at the forthcoming Annual General Meeting.

DIRECTORS:

Mr.Ashok Kumar Goenka, Director of the Company, retires by rotation and being eligible offers himself for re-appointment.

Mr.Vinod Kumar Singhi, Mr.Rajkumar Bajoria, Mr.Jagdish Chand Kumbhat and Dr. Subash R. Kamath Directors of the Company, retire by rotation at the Annual General Meeting be and are hereby appointed as an Independent Directors of the Company for a term upto five consencutive years commencing from 24th September, 2014.

LISTING WITH STOCK EXCHANGES :

As per the requirement of Clause 49 of the Listing Agreement with Stock Exchanges, the Company hereby declares that the Listing of its Shares at The Calcutta Stock Exchange Association Ltd. as well as Bombay Stock Exchange Limited continued throughout the year and the Listing Fee due till date stands paid.

DEMATERIALISATION OF SHARES :

In order to facilitate dealing in shares in the electronic mode, your Company has entered into an arrangement with the National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). With this, the members have the option to trade their dematerialised shares in the Company through NSDL or CDSL. Securities and Exchange Board of India (SEBI) has made it mandatory for all investors to trade in the shares of the Company in dematerialised form. The Company''s Shares have been allotted ISIN:INE825C01018.

AUDITORS :

M/s.M. R. Singhwi & Co., Chartered Accountants, Kolkata, Auditors of the Company, retire and being eligible offer themselves for re-appointment.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO :

Information pursuant to Section 217 (1)(e) of the Companies Act 1956 read with Companies (Disclosures of particulars in the Report of Board of Directors) Rules 1988 are given in the Annexed to this report.

PARTICULARS OF EMPLOYEES :

None of the employees of your Company is covered under Section 217(2A) of the Companies Act, 1956 read with the Companies (Particulars of Employees) Rules 1975 as amended from time to time.

DIRECTORS'' RESPONSIBILITY STATEMENT :

In compliance to the Provisions of Section 217(2AA) of the Companies Act, 1956, your Directors confirm that:

* In the preparation of the Annual Accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures.

* The Directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit of the Company for that period.

* The Directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act as well as the Companies Act 2013 (to be extent modified and applicable) for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities.

* The Directors had prepared the annual accounts on a going concern basis. CORPORATE GOVERNANCE:

The Corporate Governance form an integral part of this Report and are set out as separate annexures to this Report. The certificate from the Auditors of the company certifying compliance of condition of Corporate Governance stipulated in Clause 49 of the Listing Agreement with the Stock Exchanges is also annexed to Report on Corporate governance.

SECRETARIAL COMPLIANCE REPORT :

Pursuant to Section 383A(1) of Companies Act, 1956, the Company is statutorily required to obtain Certificate of Compliance from the practicing Company Secretary. The copy of the Compliance Certificate for the Financial Year ended 31st March, 2014 as given by M/S. S. R. Associates, Practicing Company Secretary in attached herewith as part of our Report.

DEPOSITS :

During the period under review, your Company has not accepted any deposit from the Public.

ACKNOWLEDGEMENTS:

Your Directors acknowledge the co-operation and assistance received from the Shareholders, Doctors, Banks and various Government Agencies. Your Directors wish to place on record their sincere appreciation for the contribution made by the employees.

For and on behalf of Board of Directors Ashok Kumar Goenka Chairman

Place : Kolkata Date : 30th day of May, 2014

---

Mar 31, 2013

TO THE MEMBERS:

The Directors have pleasure in submitting the 19th Annual Report together with the Audited Statement of Accounts for the year ended 31st March, 2013.

FINANCIAL HIGHLIGHTS:

The financial results of the Company are summarised below:

Particulars Year ended Year ended 31.03.2013 31.03.2012 (Rs.in lacs) (Rs.in lacs)

Income from Operations 1412.91 1326.71

Other Income 77.22 122.17

Total Income 1490.13 1448.88

Total Expenditure 1120.15 1038.76

Interest 12.14 2.82

Depreciation 72.70 73.11

Profit before Taxation 285.14 334.19

Provision for Taxation

Current Tax 73.70 72.90

Deferred Tax 0.50 (2.83)

Income Tax Adjustment for the earlier year 2.99 1.70

Net Profit 207.95 262.42

Proposed Dividend 117.27 117.27

Tax on Dividend 19.93 19.02

Transfer to General Reserve 21.00 27.00

Earnings per Share (Rs.) 6.21 7.83

OPERATIONS AND PROSPECTS:

Your company''s Division-''N G Nursing Home'' achieved modest growth and extended citizen friendly committed services specially during the Dengue affected period of the year. It is expected to continue to consolidate its position in the coming year.

Our first Division – ''N G Medicare & Calcutta Hope Infertility Clinic'' continues to face stiff competition from large number of similar establishments. Our Centre achieved to obtain NABL accreditation for it laboratory for Medical Testing as per ISO 15189 : 2007.

N G Pharmacy – Our Retail Pharmacy Division continued to operate at two outlets and has achieved modest growth during the year.

Company''s efforts to provide Total Healthcare Services from Clinics, Diagnostics, Indoor or Outpatient Services to Retail Pharmacy Dispensing in a cost effective and efficient manner will enable it to stay ahead of competitive threats and continue to perform well.

The Company acquired premises at Kolkata which is in close proximity to its operational divisions. Company intends to shift its Registered Office to the new premises and notice of same will be accordingly circulated once the same is effected.

DIVIDEND:

Your Directors recommend a Dividend of Rs. 3.50 per Equity Share (Previous Year Rs.3.50) for your consideration for the year ended 31st March, 2013. The Dividend will be paid after it is approved at the forthcoming Annual General Meeting.

DIRECTORS:

Mr.Ashok Kumar Goenka and Mr.Vinod Kumar Singhi, Directors of the Company, retire by rotation and being eligible offer themselves for re-appointment.

Mr. Ashok Bhat was appointed as a whole time director of the Company for a period of five years whose term expires on 31st August 2013. He being over stretched with many commitments expressed his desire not to be re-appointed as Whole time Director after expiry of the said term. He also expressed his intention not to continue in the office of director of the Company after a long and meritorious service. The Board commends the great zeal and dedication with which Mr.Ashok Bhat served the Company during his tenure and places on record the invaluable contribution made by him towards its growth and recommends not to re-appoint him. He will however continue to provide his valuable advisory services to the company as a Mentor. Company does not propose to appoint any Director in his place.

The Board has also appointed Mr.Rajesh Goenka as Investor Relations & Compliance Officer of the Company with effect from 1st September, 2013 in place of Mr.Ashok Bhat who retires from the Board.

LISTING WITH STOCK EXCHANGES :

As per the requirement of Clause 49 of the Listing Agreement with Stock Exchanges, the Company hereby declares that the Listing of its Shares at The Calcutta Stock Exchange Association Ltd. as well as Bombay Stock Exchange Limited continued throughout the year and the Listing Fee due till date stands paid.

DEMATERIALISATION OF SHARES :

In order to facilitate dealing in shares in the electronic mode, your Company has entered into an arrangement with the National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). With this, the members have the option to trade their dematerialised shares in the Company through NSDL or CDSL. Securities and Exchange Board of India (SEBI) has made it mandatory for all investors to trade in the shares of the Company in dematerialised form. The Company''s Shares have been allotted ISIN:INE825C01018.

AUDITORS :

M/s.M. R. Singhwi & Co., Chartered Accountants, Kolkata, Auditors of the Company, retire and being eligible offer themselves for re-appointment.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO :

Information pursuant to Section 217 (1)(e) of the Companies Act 1956 read with Companies (Disclosures of particulars in the Report of Board of Directors) Rules 1988 are given in the Annexure forming part of this report.

PARTICULARS OF EMPLOYEES :

None of the employees of your Company is covered under Section 217(2A) of the Companies Act, 1956 read with the Companies (Particulars of Employees) Rules 1975 as amended from time to time.

DIRECTORS'' RESPONSIBILITY STATEMENT :

In compliance to the Provisions of Section 217(2AA) of the Companies Act, 1956, your Directors confirm that:

- In the preparation of the Annual Accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures.

- The Directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit of the Company for that period.

- The Directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities.

- The Directors had prepared the annual accounts on a going concern basis.

CORPORATE GOVERNANCE:

The Corporate Governance form an integral part of this Report and are set out as separate annexures to this Report. The certificate from the Auditors of the company certifying compliance of condition of Corporate Governance stipulated in Clause 49 of the Listing Agreement with the Stock Exchanges is also annexed to Report on Corporate governance.

SECRETARIAL COMPLIANCE REPORT :

Pursuant to Section 383A(1) of Companies Act, 1956, the Company is statutorily required to obtain Certificate of Compliance from the practicing Company Secretary. The copy of the Compliance Certificate for the Financial Year ended 31st March, 2013 as given by M/S. S. R. Associates, Practicing Company Secretary in attached herewith as part of our Report.

DEPOSITS :

During the period under review, your Company has not accepted any deposit from the Public.

ACKNOWLEDGEMENTS:

Your Directors acknowledge the co-operation and assistance received from the Shareholders, Doctors, Banks and various Government Agencies. Your Directors wish to place on record their sincere appreciation for the contribution made by the employees.

For and on behalf of the Board of Directors

Place : Kolkata Ashok Kumar Goenka

Date : 30th day of May, 2013 Chairman

---

Mar 31, 2012

The Directors have pleasure in submitting the 18th Annual Report together with the Audited Statement of Accounts for the year ended 31st March, 2012.

FINANCIAL HIGHLIGHTS:

The financial results of the Company are summarised below:

Particulars Year ended Year ended 31.03.2012 31.03.2011 (Rs.inlacs) (Rs.inlacs)

Income from Operations 1326.71 1117.28

Other Income 122.17 67.03

Total Income 1448.88 1184.31

Total Expenditure 1038.76 855.07

Interest 2.82 -

Depreciation 73.11 75.15

Profit before Taxation 334.19 254.09

Provision for Taxation

Current Tax 72.90 69.10

Deferred Tax (2.83) (3.66)

Income Tax Adjustment for the earlier year 1.70 2.79

Net Profit 262.42 185.86

Proposed Dividend 117.27 117.27

Tax on Dividend 19.02 19.02

Transfer to General Reserve 27.00 20.00

Earnings per Share (Rs.) 7.83 5.55

OPERATIONS AND PROSPECTS:

Your company's Division-'N G Nursing Home 'achieved growth as well as consolidated its position as a widely accepted indoor establishment in South Kolkata. It is expected to further consolidate its position in the coming year.

Our first Division - 'N G Medicare & Calcutta Rope Infertility Clinic' continues to face stiff competition from different private medical establishments including large Hospitals which have come up in the city. Sustained efforts have helped us to hold on to our market share through quality services as well as penetration into newer segments.

N G Pharmacy — Our Retail Pharmacy Division continues to operate at two outlets and has grown in its operations Company's efforts to provide Total Healthcare Services from Clinics. Diagnostics, Indoor or Outpatient Services to Retail Pharmacy Dispensing in a cost effective and efficient manner will enable it to stay ahead of competitive threats and continue to perform well.

DIVIDEND:

Your Directors recommend a Dividend of Rs 3.50 per Equity Share (Previous Year Rs 3.50) for your consideration for the year ended 31 st March, 2012. The Dividend will be paid after it is approved at the forthcoming Annual General Meeting.

DIRECTORS:

Shri Rajkumar Rajoria and Dr Subash R Kamath, Directors of the Company, retire by rotation and being eligible offer themselves for re-appointment.

Shri Banwari Lal Goenka. Director retires at the conclusion of the ensuing Annual General Meeting by rotation and has expressed his intention to step down from the said assignment after a long and meritorious service. The Board commends the great real and dedication with which Shri Banwari Lal Goenka served the Company during his tenure and places on record the invaluable contribution made by him towards its growth and recommends not to re-appoint him.

LTSTTNG WTTH STOCK EXCHANGES :

As per the requirement of Clause 49 of the Listing Agreement with Stock Exchanges, the Company hereby declares that the Listing of its Shares at The Calcutta Stock Exchange Association Ltd. as well as Bombay Stock Exchange Limited continued throughout the year and the Listing Fee due till date stands paid.

DEMATERIALTSATTON OF SHARES :

In order to facilitate dealing in shares in the electronic mode, your Company has entered into an arrangement with the National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). With this, the members have the option to trade their dematerialised shares in the Company through NSDL or CDSL. Securities and Exchange Board of India (SEBI) has made it mandatory for all investors to trade in the shares of the Company in dematerialised form. The Company's Shares have been allotted ISEV:INE 825C01018.

AUDITORS:

M/s.IvL R. Singhwi & Co., Chartered Accountants, Kolkata, Auditors of the Company, retire and being eligible offer themselves for re-appointment.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO :

Information pursuant to Section 217 (l)(e) of the Companies Act 1956 read with Companies (Disclosures of particulars in the Report of Board of Directors) Rules 1988 arc given in the Annexure forming part of this report.

PARTTCULARS OF EMPLOYEES :

None of the employees of your Company is covered under Section 217(2A) of the Companies Act, 1956 read with the Companies (Particulars of Employees) Rules 1975 as amended from time to time.

DIRECTORS' RESPONSIBILITY STATEMENT :

In compliance to the Provisions of Section 217(2AA) of the Companies Act 1956, your Directors confirm that:-

- In the preparation of the Annual Accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures.

- The Directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit of the Company for that period.

- The Directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities.

- The Directors had prepared the annual accounts on a going concern basis

CORPORATE GOVERNANCE:

The Corporate Governance forms an integral part of this Report and are set out as separate annexure to this Report. The certificate from the Auditors of the company certifying compliance of condition of Corporate Governance stipulated in Clause 49 of the Listing Agreement with the Stock Exchanges is also annexed to Report on Corporate governance.

SECRETARIAL COMPLIANCE REPORT :

Pursuant to Section 183 A(1) of Companies Act, 1956, the Company is statutorily required to obtain Certificate of Compliance from the practising Company Secretary. The copy of the Compliance Certificate for the Financial Year ended 31st March, 2012 as given by M/S. S. R. Associates, Practicing Company Secretary in attached herewith as part of our Report.

DEPOSITS :

During the period under review, your Company has not accepted any deposit from the Public.

ACKNOWLEDGEMENTS:

Your Directors acknowledge the co-operation and assistance received from the Shareholders, Doctors, Banks and various Government Agencies. Your Directors wish to place on record their sincere appreciation for the contribution made by the employees.

For and on behalf of the Board of Directors

Place : Kolkata Ashok Kumar Goenka

Date :30th day of

May, 2012 Chairman

---

Mar 31, 2011

DIRECTORS' REPORT TO THE MEMBERS:

The Directors have pleasure in submitting the 17th Annual Report together with the Audited Statement of Accounts for the year ended 31 st March, 2011.

FINANCIAL HIGHLIGHTS:

The financial results of the Company are summarised below:

Particulars Year ended Year ended 31.03.2011 31.03.2010 (Rs. in lacs) (Rs. in lacs)

Income from Operations 1117.28 1011.29

Omer Income 67.03 98.96

Total Income 1184.31 1110.25

Total Expenditure 853.15 767.09

Interest 1.92 3.90

Depreciation 75.15 67.78

Profit before Taxation 254.09 271.48

Provision for Taxation

Current Tax 69.10 61.87

Deferred Tax (3.66) (2.24)

Income Tax Adjustment for the earlier year 2.79 -

Net Profit 185.86 211.85

Proposed Dividend 117.27 100.51

Tax on Dividend 19.02 17.08

Transfer to General Reserve 20.00 22.00

Earnings per Share (Rs.) 5.55 6.32

OPERATIONS AND PROSPECTS:

During me year your Company's Division "N. G. Nursing Home' achieved wider growth in it's operations and received wider patronage from both Doctors and Citizens in utilizing its services. The Division is poised to further consolidate its position and achieve higher capacity utilization in the coming year.

Our First Division- 'N. G. Medicare & Calcutta Hope Infertility Clinic' continues to enjoy wide patronage in South Kolkata despite stiff competition from several similar setups which have come up in the city in recent years. Our efforts have been to hold on to our market share in this competitive phase of the evolution of the segment through cost effective and quality services.

N. G. Pharmacy - Our retail Pharmacy division continues to operate at two outlets and has grown in its operations.

Company's efforts to provide Total Healthcare Services from Clinics, Diagnostics, Indoor or Outpatient Services to Retail Pharmacy Dispensing in a cost effective and efficient manner will enable it to stay ahead of competitive threats and continue to perform well.

DIVIDEND:

Your Directors recommend a Dividend of Rs. 3.50 per Equity Share (Previous Year Rs.3.00) for your consideration for the year ended 31 st March, 2011. The Dividend will be paid after it is approved at the forthcoming Annual General Meeting.

DIRECTORS:

Shri Banwari Lai Goenka and Shri Jagdish Chand Kumbhat, Directors of the Company, retire by rotation and being eligible offer themselves for re-appointment.

LISTING WITH STOCK EXCHANGES:

As per the requirement of Clause 49 of the Listing Agreement with Stock Exchanges, the Company hereby declares that the Listing of its Shares at The Calcutta Stock Exchange Association Ltd. as well as Bombay Stock Exchange Limited continued throughout the year and the Listing Fee due till date stands paid.

DEMATERIALISATION OF SHARES :

In order to facilitate dealing in shares in the electronic mode, your Company has entered into an arrangement with the National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). With this, the members have the option to trade their dematerialised shares in the Company through NSDL or CDSL. Securities and Exchange Board of India (SEBI) has made it mandatory for all investors to trade in the shares of the Company in dematerialised form. The Company's Shares have been allotted ISIN:INE825C01018.

AUDITORS:

M/s.M. R. Singhwi & Co., Chartered Accountants, Kolkata, Auditors of the Company, retire and being eligible offer themselves for re-appointment.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO:

Information pursuant to Section 217 (l)(e) of the Companies Act 1956 read with Companies (Disclosures of particulars in the Report of Board of Directors) Rules 1988 are given in the Annexure forming part of this report.

PARTICULARS OF EMPLOYEES:

None of the employees of your Company is covered under Section 217(2A) of the Companies Act, 1956 read with the Companies (Particulars of Employees) Rules 1975 as amended from time to time.

DIRECTORS' RESPONSIBILITY STATEMENT:

In compliance to the Provisions of Section 217(2AA) of the Companies Act, 1956, your Directors confirm that:

In the preparation of the Annual Accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures.

The Directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view oil the state of affairs of the Company at the end of the financial year and of the profit of the Company for mat period.

The Directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities.

- The Directors had prepared the annual accounts on a going concern basis.

CORPORATE GOVERNANCE:

The Corporate Governance form an integral part of this Report and are set out as separate annexures to this Report. The certificate from the Auditors of the company certifying compliance of condition of Corporate Governance stipulated in Clause 49 of the Listing Agreement with the Stock Exchanges is also annexed to Report on Corporate governance.

DEPOSITS:

During the period under review, your Company has not accepted any deposit from the Public.

ACKNOWLEDGEMENTS:

Your Directors acknowledge the co-operation and assistance received from the Shareholders, Doctors, Banks and various Government Agencies. Your Directors wish to place on record their sincere appreciation for the contribution made by the employees.

For and on behalf of the Board of Directors

Place :Kolkata ASHOK KUMAR GOENKA

Dated: 30th day of May, 2011 CHAIRMAN

---

Mar 31, 2010

The Directors have pleasure in submitting the 16th Annual Report together with the Audited Statement of Accounts for the year ended 31st March, 2010.

FINANCIAL HIGHLIGHTS :

The financial results of the Company are summarised below :

Particulars Year ended Year ended

31.03.2010 31.03.2009

(Rs.in lacs) (Rs.in lacs)

Income from Operations 1011.29 953.59

Other Income 98.96 14.04

Total Income 1110.25 967.63

Total Expenditure 767.09 720.70

Interest 3.90 ---

Depreciation 67.78 71.72

Profit before Taxation 271.48 175.21 Provision for Taxation

Current Tax 61.87 61.24

Deferred Tax (2.24) (5.76)

Fringe Benefit Tax - 1.24

Net Profit 211.85 118.49

Proposed Dividend 100.51 97.16

Tax on Dividend 17.08 16.51

Transfer to General Reserve 22.00 15.00

Earnings per Share (Rs.) 6.32 3.54

OPERATIONS AND PROSPECTS :

During the year your Companys Division N. G. Nursing Home further consolidated its operations arid could achieve a wider base of both Doctors and Patients utilizing its services. Company also obtained necessary sanctions and developed the infrastructure on the ground floor of its premises, the benefit of which will accrue in the coming years. N.G.Nursing Home also secured approval under section 17(2) of the Income Tax Act 1961 for a period of 3 years.

N. G. Medicare & Calcutta Hope Infertility Clinic Our first Division continues to enjoy wide patronage of all sections of citizens of South Kolkata. However intense competition in this segment of healthcare compounded with pressure on purchasing capacity in hands of citizens due to high food inflation and economic slow down continue to come in the way of achieving growth. Investments were made to replace old CT Scan machine as well as Color Doppler during the year.

N. G. Pharmacy Our retail Pharmacy division could start its second retail outlet at the premises of N.G.Nursing Home at Southern Avenue, Kolkata towards the end of the year. The benefit of this startup will accrue in the coming year. Earlier retail outlet at Rash Behari Avenue continued to draw wider patronage.

Companys strong emphasis on cost controls, efficient management & operations, fiscal discipline and Quality adherence will enable it to face the competitive threats that it faces and reflect in performance in coming years.

DIVIDEND :

Your Directors recommend a Dividend of Rs. 3.00 per Equity Share (Previous Year Rs.2.90) for your consideration for the year ended 31 st March, 2010.The Dividend will be paid after it is approved at the forthcoming Annual General Meeting.

DIRECTORS :

Shri Ashok Kumar Goenka and Shri Vinod Singhi, Directors of the Company, retire by rotation and being eligible offer themselves for re-appointment.

LISTING WITH STOCK EXCHANGES :

As per the requirement of Clause 49 of the Listing Agreement with Stock Exchanges, the Company hereby declares that the Listing of its Shares at The Calcutta Stock Exchange Association Ltd. as well as Bombay Stock Exchange Limited continued throughout the year and the Listing Fee due till date stands paid.

DEMATERIALISATION OF SHARES :

In order to facilitate dealing in shares in the electronic mode, your Company has entered into an arrangement with the National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL). With this, the members have the option to trade their dematerialised shares in the Company through NSDL or CDSL. Securities and Exchange Board of India (SEBI) has made it mandatory for all investors to trade in the shares of the Company in dematerialised form. The Companys Shares have been allotted ISIN:INE825C01018.

AUDITORS :

M/s.M. R. Singhwi & Co., Chartered Accountants, Kolkata, Auditors of the Company, retire and being eligible offer themselves for re-appointment.

CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION AND FOREIGN EXCHANGE EARNINGS AND OUTGO :

Information pursuant to Section 217 (1)(e) of the Companies Act 1956 read with Companies (Disclosures of particulars in the Report of Board of Directors) Rules 1988 are given in the Annexure forming part of this report.

PARTICULARS OF EMPLOYEES :

None of the employees of your Company is covered under Section 217(2A) of the Companies Act, 1956 read with the Companies (Particulars of Employees) Rules 1975 as amended from time to time.

DIRECTORS RESPONSIBILITY STATEMENT :

In compliance to the Provisions of Section 217(2AA) of the Companies Act, 1956, your Directors confirm that :

- In the preparation of the Annual Accounts, the applicable accounting standards had been followed along with proper explanation relating to material departures.

- The Directors had selected such accounting policies and applied them consistently and made judgments and estimates that are reasonable and prudent so as to give a true and fair view of the state of affairs of the Company at the end of the financial year and of the profit of the Company for that period.

- The Directors had taken proper and sufficient care for the maintenance of adequate accounting records in accordance with the provisions of this Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities.

- The Directors had prepared the annual accounts on a going concern basis.

CORPORATE GOVERNANCE :

The Corporate Governance form an integral part of this Report and are set out as separate annexures to this Report. The certificate from the Auditors of the company certifying compliance of condition of Corporate Governance stipulated in Clause 49 of the Listing Agreement with the Stock Exchanges is also annexed to Report on Corporate governance.

DEPOSITS :

During the period under review, your Company has not accepted any deposit from the Public.

ACKNOWLEDGEMENTS :

Your Directors acknowledge the co-operation and assistance received from the Shareholders, Doctors,Banks and various Government Agencies. Your Directors wish to place on record their sincere appreciation for the contribution made by the employees.

For and on behalf of the Board of Directors

ASHOK KUMA.R GOENKA

CHAIRMAN

Place :Kolkata

Dated :29th day of May,2010